Search

Search Results
Results 851 - 860 of 886 for Acute Lymphoblastic Leukemia
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Evoltra intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Sprycel intended for persons living in Australia.
  • Health - 23 Jun 2023
    Chemotherapy was first developed at the beginning of the 20th century, although it was not originally intended as a cancer treatment.
  • Health - 9 Jun 2023
    Substantial evidence exists to suggest that the low-power, low-frequency, electromagnetic radiation emitted in the average household does not pose a risk to either short or long-term health. However,...
  • Health - 23 Feb 2023
    Immunotherapy is a disease treatment that works by initiating, improving, or suppressing the body’s immune response.
  • Life Sciences - 16 Dec 2022
    Bispecific antibodies are comprised of two monoclonal antibodies held together by a flexible peptide linker.
  • News - 12 Dec 2022
    A patient with relapsed T cell leukemia has been given base-edited T-cells in a world-first use of a base-edited cell therapy, in a 'bench-to-bedside' collaboration between UCL and Great Ormond Street...
  • News - 15 Aug 2022
    Deborah Lewis rose from bed before dawn and signed in to her phone so she could begin delivering fast food, coffee, and groceries to residents in this western patch of the Mojave Desert where test...
  • Life Sciences - 28 May 2021
    Tyrosine kinase inhibitors, which reduce or eliminate the intensity of aberrant signals, are under thorough investigation as anticancer agents.
  • Health - 10 May 2021
    Adoptive T cell therapy is a promising type of immunological treatment that utilizes the immune system to fight diseases such as cancer.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.